Submitted by Anonymous (not verified) on 25 June 2026 - 12:42
Human medicines European public assessment report (EPAR): Trajenta, linagliptin, Date of authorisation: 23/08/2011, Revision: 24, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Trajenta, linagliptin, Date of authorisation: 23/08/2011, Revision: 24, Status: Authorised